Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells in Children With Cerebral Palsy: a Randomized, Double-blind Cross-over Study

NCT02983708 is registered in ClinicalTrials.gov with Hanyang University Seoul Hospital as lead sponsor.

NCT NCT02983708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02983708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells in Children With Cerebral Palsy: a Randomized, Double-blind Cross-over Study
Lead sponsor
Hanyang University Seoul Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2011
Completion date
September 30, 2014
Enrollment
57 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy, g-csf, neurodegeneration, peripheral blood mononuclear cells